Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-03

FDA Approved: IRINOTECAN HYDROCHLORIDE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s Original Application for irinotecan hydrochloride, establishing a generic version of irinotecan for cancer treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

ORIG AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)